Other Assets, Current of REGENXBIO Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
REGENXBIO Inc. quarterly Other Assets, Current in USD history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • REGENXBIO Inc. Other Assets, Current for the quarter ending 30 Sep 2025 was $19,472,000, a 21% increase year-over-year.
Source SEC data
View on sec.gov
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

REGENXBIO Inc. Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $19,472,000 +$3,390,000 +21% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $19,479,000 -$4,017,000 -17% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $16,082,000 -$11,215,000 -41% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $13,774,000 -$6,629,000 -32% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $16,082,000 -$7,265,000 -31% 30 Sep 2024 10-Q 12 May 2025 2025 Q1
Q2 2024 $23,496,000 +$1,261,000 +5.7% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $27,297,000 +$4,294,000 +19% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $20,403,000 +$11,051,000 +118% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $23,347,000 +$16,499,000 +241% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $22,235,000 +$13,518,000 +155% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $23,003,000 +$15,824,000 +220% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $9,352,000 -$844,000 -8.3% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $6,848,000 +$962,000 +16% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $8,717,000 +$3,553,000 +69% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $7,179,000 +$4,299,000 +149% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $10,196,000 +$8,243,000 +422% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $5,886,000 -$1,311,000 -18% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $5,164,000 -$2,107,000 -29% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $2,880,000 -$4,152,000 -59% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $1,953,000 -$2,246,000 -53% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $7,197,000 +$4,783,000 +198% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $7,271,000 +$4,990,000 +219% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $7,032,000 +$3,037,000 +76% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $4,199,000 +$368,000 +9.6% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $2,414,000 -$2,420,000 -50% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $2,281,000 -$66,000 -2.8% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $3,995,000 +$1,787,000 +81% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $3,831,000 +$2,419,000 +171% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 $4,834,000 +$3,444,000 +248% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $2,347,000 +$1,095,000 +87% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $2,208,000 +$1,286,000 +139% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 $1,412,000 +$402,000 +40% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 $1,390,000 -$610,000 -30% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 $1,252,000 -$185,000 -13% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 $922,000 -$378,000 -29% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $1,010,000 +$159,000 +19% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q3 2016 $2,000,000 +$1,873,000 +1475% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $1,437,000 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 $1,300,000 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 $851,000 31 Dec 2015 10-K 07 Mar 2017 2016 FY
Q3 2015 $127,000 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.